Twist Bioscience (NASDAQ:TWST)报告其季度每股亏损为$(0.53)，这比分析师预期的$(0.64)高出17.19%。相比去年的每股亏损$(0.75)，增加了29.33%。公司报告季度销售额为$88.71百万，超过了分析师预期的$86.97百万，增幅为2.00%。这比去年同期的销售额$71.50百万增加了24.08%。
以上内容来自Benzinga Earnings专栏，原文如下：
Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.64) by 17.19 percent. This is a 29.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $88.71 million which beat the analyst consensus estimate of $86.97 million by 2.00 percent. This is a 24.08 percent increase over sales of $71.50 million the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.